-
Johnson & Johnson Acquires Momenta Pharmaceuticals for $6.5B
Post on 10/1/20
-
DiamiR Awarded $3.86M in Two Grants from the NIH
Post on 10/1/20
-
Fairmount Partners Advises INVIVO Communications in Sale to Red Nucleus
Post on 10/1/20
-
Why Celldex Has Been A Big Winner In 2020
Post on 10/1/20
-
Better Buy: GlaxoSmithKline vs. Pfizer
Post on 10/1/20
-
Interview with Ted Quinn, CEO & Founder of Activate Care
Post on 9/30/20
-
PMV Pharma Closes $243.5M IPO
Post on 9/30/20
-
FlowMetric Life Sciences and Penn State University Collaborates
Post on 9/29/20
-
Otsuka America Pharmaceutical Earns Designation as a Great Place to Work-Certified Company In 2020
Post on 9/29/20
-
Aclipse Therapeutics Awarded AUD 1 Million Grant from FightMND
Post on 9/29/20
-
AmerisourceBergen Will Soon Be Rewarded For Quietly Growing Profits
Post on 9/29/20
-
Inovio Coronavirus Vaccine Candidate Trial Halted Due to FDA Inquiry
Post on 9/29/20
-
Palatin Technologies Announces Fourth Quarter 2020 Financial Results
Post on 9/28/20
-
Immunome Aims For $30 Million U.S. IPO
Post on 9/28/20
-
Is Inovio Worth Buying During the Market Correction?
Post on 9/28/20
-
If You Invested $1,000 in Inovio Pharmaceuticals in January, This Is How Much You'd Have Now
Post on 9/28/20
-
PMV Pharma Prices IPO
Post on 9/27/20
-
For Investors, Is Owning Johnson & Johnson Stock a Vice or a Virtue?
Post on 9/25/20
-
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate
Post on 9/23/20
-
Why Pfizer's Latest Big Win Makes It an Even Better Buy for Retirees
Post on 9/23/20
-
PHOENIX Rehabilitation & Health Services Launches New Brand Identity As Phoenix Physical Therapy
Post on 9/22/20
-
Marinus Announces One-for-Four Reverse Stock Split
Post on 9/22/20
-
PMV Pharmaceuticals Seeks $125 Million To Enter Trials
Post on 9/22/20
-
Integral Molecular Awarded Grant from the Commonwealth of Pennsylvania
Post on 9/21/20
-
Henry Mortimer, citybiz Editor-at-Large, Interview with Mark Olcott, CEO of VitusVet
Post on 9/22/20